Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer

NCT00034541 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

BIOLOGICAL: cetuximab
DRUG: paclitaxel
DRUG: carboplatin

Sponsor

Eli Lilly and Company

Collaborators

[object Object]
[object Object]
[object Object]